Research and Markets: Cell Culture: The Market for Media, Sera and Reagents to 2017
DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/vhv5gt/cell_culture_the) has announced the addition of the "Cell Culture: The Market for Media, Sera and Reagents" report to their offering.
“Cell Culture: The Market for Media, Sera and Reagents”
The choice of cells to use in biopharmaceutical production depends on a number of factors, some technical and some economic. Bacteria and yeast, for instance, are relatively simple to grow. Each cell of a bacterium or yeast is an independent organism capable of its own metabolism. Yeasts and bacteria have fairly simple nutritional needs and grow well suspended in a liquid medium, as well as in large fermentors.
This report is focused on cell culture used in the research and production of biopharmaceuticals. In the pharmaceutical industry, cell culture is a major foundation of biopharmaceutical development, bioprocessing and manufacturing. Biopharmaceutical products are developed from large, complex protein molecules, which require equally complex manufacturing methods and an array of analytical techniques. As growing cells for biopharmaceutical production is slow, expensive and complicated, optimizing cell culture development is of paramount concern to companies developing biopharmaceuticals. Forecasts and current market sizing are provided in three specific segments:
Media, Sera, and Reagents exhaustive report provides specific information on:
- Market Size, of the Cell Culture Media Segment Market, Sera Segment Market and Reagent Segment Market through 2017
- Market Share Estimate for Animal-Derived, Component Free Media
- Market Share Estimate for Serum-Free Media
- Market Share Estimate for Chemically-Defined Media
- Competitive Market Share by leading supplier as of 2012
- Estimated Market by Region (North America, Europe, Asia U.S.)
- Key Market Drivers and Restraints for suppliers, including discussions of biopharmaceutical pipelines, biomedical R&D directions, and the future of transgenic plant and animal production.
- Review of the various expression systems (Bacteria, Yeast, Insect, and Mammal) and the biopharmaceutical product manufactured by these systems
The report contains a discussion of the preferences in media types vying for dominance in the market, including the following:
- ADCF - animal derived component free media
- CD - chemically defined media
- CSFM - complete serum free medium
- PF - protein free media
- SF - serum free media
- SFM - serum free medium
Key Topics Covered:
CHAPTER ONE: EXECUTIVE SUMMARY
CHAPTER TWO: GENETICALLY MODIFIED CELLS FOR BIOPHARMACEUTICAL DEVELOPMENT
CHAPTER THREE: CELL CULTURE TECHNOLOGY
CHAPTER FOUR: CELL CULTURE MARKET CURRENT AND FUTURE TRENDS
CHAPTER FIVE: COMPANY PROFILES
- Advanced Biotechnologies, Inc.
- Affymetrix, Inc.
- AMRESCO, Inc.
- Atlanta Biologicals, Inc.
- BD Biosciences
- Bioreclamation Inc
- Cell Essentials, Inc.
- CellGenix Technologie Transfer GmbH
- ClonTech Laboratories, inc.
- Corning Life Sciences
- EMD Millipore
- GE Healthcare Live Sciences
- Gemini Bio-Products
- Irvine Scientific
- J R Scientific, Inc.
- Life Technologies Corporation
- Lonza Bioscience
- MP Biomedicals
- Novozymes Biopharma US Inc
- PromoCell GmbH
- Quality Biological, Inc.
- R&D Systems, Inc.
- SAFC Biosciences
- SBH Sciences
- Selexis SA
- SeraCare Life Sciences, Inc.
- Sera Laboratories International Ltd
- Stemcell Technologies Inc.
- Thermo Fisher Scientific, Inc.
For more information visit http://www.researchandmarkets.com/research/vhv5gt/cell_culture_the